US 11352363
Spiropyrrolidine derived antiviral agents
granted A61PA61P31/14
Quick answer
US patent 11352363 (Spiropyrrolidine derived antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P31/14